Table 2.
Exercise measure | Intervention group (n=44) | Control group (n=41) | P value |
BMI (kg/m2), median (IQR) | –0.60 (–1.07 to 0.16) | –0.32 (–0.74 to 0.01) | .09 |
Hemoglobin A1c (%), median (IQR) | –0.55 (–1.53 to –0.07) | –0.70 (–1.40 to 0.40) | .46 |
Body fat (%), median (IQR) | –1.80 (–2.95 to –0.10) | –0.80 (–1.73 to 0.65) | .01 |
HOMA-IRa, median (IQR) | 0.07 (–0.51 to 1.06) | –0.17 (–1.48 to 1.29) | .23 |
HOMA-βb, median (IQR) | 1.44 (–20.70 to 21.18) | 3.64 (–19.02 to 42.47) | .52 |
Resting heart rate (bpmc), median (IQR) | 2.00 (–3.00 to 10.50) | 4.00 (–2.00 to 10.00) | .52 |
Step test (bpm), median (IQR) | –2.00 (–9.50 to 3.00) | 1.00 (–3.00 to 10.00) | .02 |
Muscle strength (repetitions), mean (SD) | –0.90 (4.60) | –0.78 (4.16) | .91 |
aHOMR-IR: homeostasis model assessment for insulin resistance.
bHOMA-β: homeostasis model assessment for β-cell function.
cbpm: beats per minute.